CPIC 2026 | Protheragen Session: Global Biomedical Cross-Border Transactions

Jun 25,2026

Jointly explore sustainable and high-quality ways to expand globally.

Entering the 3.0 era of self exemption, Chinese pharmaceutical companies sit at the table

Jun 25,2026

AbbVie invests $10.9 billion in ultra long term investments

The 'Chinese genes' of the $2 trillion era

Jun 25,2026

From 5% to two-thirds

2026: Recovery, Breakthrough, and Gaming of Universal CAR-T

Jun 24,2026

Technical value is repriced by clinical data

Agenda Released! North America-China Innovative Drug Industry Collaboration Special Session

Jun 22,2026

Looking forward to exploring the North American pathway for Chinese innovative drugs going global with you.

Synthesize deadly 'new aristocrats' soaring wildly

Jun 20,2026

PRMT5 inhibitor 'partner' RAS

CPIC 2026 | "Lu Lu" Debuts: The Spirit of the Eastern Unicorn, Empowering Innovation

Jun 19,2026

Injected a unique Eastern cultural blessing into CPIC 2026
< 1234...20 > proceed page